Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis
By K. Connor, N. Krah, R. J. Dennison, C. Aderman, Jing Chen, K. Guerin, P. Sapieha, A. Stahl, K. Willett, Lois E. H. Smith. Nature Protocols, 2009
731 citations recorded by the source corpus.
The mouse model of oxygen-induced retinopathy (OIR) has been widely used in studies related to retinopathy of prematurity, proliferative diabetic retinopathy and in studies evaluating the efficacy of antiangiogenic compounds. In this model, 7-d-old (P7) mouse pups with nursing mothers are subjected to hyperoxia (75% oxygen) for 5 d, which inhibits retinal vessel growth and causes significant vessel loss. On P12, mice are returned to room air and the hypoxic avascular retina triggers both normal vessel regrowth and retinal neovascularization (NV), which is maximal at P17. Neovascularization spontaneously regresses between P17 and P25. Although the OIR model has been the cornerstone of studies investigating proliferative retinopathies, there is currently no harmonized protocol to assess aspects of angiogenesis and treatment outcome. In this protocol we describe standards for mouse size, sample size, retinal preparation, quantification of vascular loss, vascular regrowth, NV and neovascular regression.
Subfields: Ophthalmology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/655a2c4ecdb2f0707efd833cba11af74e31badee
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- A. Stahl
- P. Sapieha
- K. Connor
- Jing Chen
- R. J. Dennison
- N. Krah
- Molly R. Seaward
- C. Aderman
Citations in the corpus
- The mouse retina as an angiogenesis model. (2010, methodology): “6a–c).(73) Similar to VO, quantification of NV is performed on retinal whole mounts, usually at the peak of proliferative retinopathy at P17.”